MARATTO

article · Karbala International Journal of Modern Science

Biomedical Applications of Chasmanthera dependens stem extract mediated silver nanoparticles as Antimicrobial, Antioxidant, Anticoagulant, thrombolytic, and Larvicidal agents

201956 citationsOpen accessLadoke Akintola University of Technology

In plain language

Silver nanoparticles were synthesised using the stem extract of the plant Chasmanthera dependens. Structural and chemical analysis confirmed the formation of cubically shaped silver nanoparticles with sizes between 24.53 and 92.38 nanometres. Laboratory evaluations showed that the particles possessed targeted antibacterial properties, inhibiting Klebsiella pneumoniae at concentrations of 80 and 100 micrograms per millilitre while showing minimal effect on other tested bacteria. The nanoparticles also functioned as potent larvicides against Aedes aegypti mosquito larvae, achieving lethal concentrations of 7.15 and 20.86 micrograms per millilitre for fifty and ninety percent mortality respectively within one hour. Furthermore, the synthesised particles showed free radical scavenging capability at all tested concentrations, high anticoagulant efficacy, and the ability to dissolve blood clots with a clot lysis rate of 45.61 percent.

Key takeaways

  • Silver nanoparticles ranging in size from 24.53 to 92.38 nanometres were successfully synthesised using Chasmanthera dependens stem extract.
  • The biosynthesised nanoparticles inhibited Klebsiella pneumoniae bacteria at 80 and 100 micrograms per millilitre.
  • The particles showed strong larvicidal action against Aedes aegypti mosquito larvae within one hour of exposure.
  • Laboratory assays demonstrated high anticoagulant activity, a 45.61 percent clot lysis rate, and consistent antioxidant radical scavenging.

Why it matters

Finding natural and sustainable ways to produce functional nanomaterials is important for developing new health and pest control solutions. Plant-mediated synthesis provides an alternative method for generating silver nanoparticles that can simultaneously target harmful bacteria, control disease-carrying mosquitoes, and offer potential properties for blood clot management and antioxidant protection.

Commercialisation angle

The findings suggest potential applications in developing vector control formulations against mosquitoes and targeted antibacterial or therapeutic agents for thrombosis and oxidative stress. Potential users include pharmaceutical developers and public health bodies. This work represents early-stage laboratory research, as evaluations were limited to initial in vitro and larvicidal assays without safety, formulation, or in vivo testing reported.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

The stem extract of Chasmanthera dependens was used in the biofabrication of silver nanoparticles (AgNPs) in this study. The AgNPs was characterised using UV-visible spectroscopy, Field Emission Scanning Electron Microscope (FESEM), EDX, and the Fourier Transform Infrared Spectroscopy (FTIR). Antibacterial, antioxidant, anticoagulant, thrombolytic and larvicidal activities of the biosynthesised nanoparticles were carried out. There was a peak at 418 nm with a strong silver peak observed around 2.7KeV when the EDX analysis was carried out. The FESEM showed a large number of cubically shaped nanoparticles with sizes ranging from 24.53 to 92.38 nm. CDE-AgNPs was effective against Klebsiella pneumoniae at 80 µg/ml and 100 µg/ml concentrations while little or no inhibition observed with other bacterial isolates used. CDE-AgNPs displayed potent activity with LC50 and LC90 of 7.15 µg/ml and 20.86 µg/ml respectively against the Aedes aegypti mosquito larva after 1hr of exposure. The synthesised nanoparticles displayed scavenging activity of DPPH at all concentrations. High anticoagulant efficacy was displayed, while 45.61% clot lysis was observed. This study therefore demonstrated the effectiveness of biosynthesised Chasmanthera dependens stem extract silver nanoparticles as antimicrobial, antioxidant, anticoagulant, thrombolytic and larvicidal agents.

Research topics

  • Nanoparticles: synthesis and applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.33640/2405-609x.1018

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.